Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Cover Story: The AI Boom’s Unsettling Paradox
New Flight System Targets ‘Blind Spots’ in China’s Low-Altitude Economy
LATEST
New Flight System Targets ‘Blind Spots’ in China’s Low-Altitude Economy
Cover Story: The AI Boom’s Unsettling Paradox
AI Keeps China, U.S. From Decoupling Despite Trade Tensions, Insiders Say
Wingtech Demands Return of Nexperia Control After Dutch Freeze Pause
Intel Pivots to Custom Chips to Tap China’s Trillion-Yuan Computing Markets
Geely Leads $141 Million Round for Tsinghua-Linked Robotics Startup
China’s Giant Neutrino Detector Delivers First Results With Record Precision
China Unicom Taps Veteran Executive as Chairman to Navigate Telecom Transition
Chinese Self-Driving Firms Accelerate Into Middle East, Southeast Asia
Baidu Posts Record Revenue Decline as Ad Business Falters
Xiaomi’s EV, AI Units Post First Quarterly Profit
China’s Agricultural Drone Makers Pivot to Smarter Navigation as Size Race Ends
Alibaba Renames AI App to Stand Out in China’s Crowded Chatbot Market
Investors Flock to Chinese eVTOLs Chasing Regulatory Green Lights
Nexperia Headquarters Rachets Up Feud With China Unit With Salvo of Accusations
Robot-Maker Unitree Steps Closer to China IPO
Tencent Says Talks With Apple on WeChat Game Fees Are Advancing
Baidu Unveils Ambitious AI Chip Roadmap, Targeting 1 Million-Card Cluster by 2030
Tencent’s Profit Rises 19% on Overseas Gaming and AI-Powered Ad Surge
Caixin Summit: Design, Commercialization Key to China’s Low-Altitude Economy Taking Off, Industry Insider Says

By Han Wei / Dec 29, 2018 02:40 AM / Business & Tech

Photo: VCG

Photo: VCG

An initial investigation of herbal medicines and health foods producer Quanjian Group Co. Ltd. found that the company committed violations by exaggerating the benefits of its products, the state broadcaster China Central Television reported Friday.

A formal investigation has been initiated against Quanjian by the Tianjin city market regulator on allegations of violating market competition law, said the report.

Tianjin-based Quanjian has been under public scrutiny since Dingxiangyuan, an online health news portal, published an article Tuesday reporting that the company exaggerated the benefits of its products, which contributed to the 2015 death of a 4-year-old with cancer. Tianjin authorities sent inspectors to the company after the report went viral.

Quanjian also faces questions on whether it was involved in pyramid sales, which are banned in China. An official on the inspection team said the probe is still underway, according to the CCTV report.

Related: ‘Miracle’ Herbal Cures Accused of Contributing to Child's Death

Share this article
Open WeChat and scan the QR code